This post has been de-listed
It is no longer included in search results and normal feeds (front page, hot posts, subreddit posts, etc). It remains visible only via the author's post history.
Dr quay mentions in this article about potential readouts in April and June , also talks about discussions with the FDA about phase 3 trials
Also discusses about a possible partnership moving forward after phase 2? How does that work in ter.s of value to share holders ? Is it a more profitable long term plan or is a buyout more preferable?
Buyout is preferable. Quay himself has said he wants to sell to big pharma eventually. ATOS would need to raise more money to carry this drug to market, plus we donβt have a sales/marketing team, etc.
Big pharma typically buys promising drugs after a good phase 2 so they can run phase 3 themselves.
Subreddit
Post Details
- Posted
- 9 months ago
- Reddit URL
- View post on reddit.com
- External URL
- reddit.com/r/AtossaThera...